Minna Hassinen

Minna Hassinen is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Director of Global Adstiladrin SME at Ferring Pharmaceuticals since May 2023, Minna is responsible for providing scientific and CMC/regulatory support for cross-functional projects. Prior to this role, Minna held various leadership positions at FinVector Oy, including Manufacturing, Science and Technology Director and Analytical Director, from April 2014 to May 2023. Additional experience includes a role as Senior Manufacturing Quality Control Executive at FKD Therapies OY and QC Scientist/Project Manager at Ark Therapeutics. Minna's career began in academia, with positions as a Molecular Biologist at Kuopion yliopisto and Researcher PhD Student at the University of Eastern Finland, where Minna also earned a Licentiate degree in Biochemistry, molecular genetics, and a Master's degree in Biochemistry.